Standex International (SXI) At $104.53 Forms Top; Blair William & Company Has Boosted Its Abbvie (ABBV) Stake

December 6, 2017 - By Adrian Mccoy

Blair William & Company increased Abbvie Inc (ABBV) stake by 5.13% reported in 2017Q2 SEC filing. Blair William & Company acquired 38,894 shares as Abbvie Inc (ABBV)’s stock rose 6.17%. The Blair William & Company holds 796,612 shares with $57.76M value, up from 757,718 last quarter. Abbvie Inc now has $150.34B valuation. The stock decreased 1.30% or $1.24 during the last trading session, reaching $94.17. About 886,756 shares traded. AbbVie Inc. (NYSE:ABBV) has risen 10.63% since December 6, 2016 and is uptrending. It has underperformed by 6.07% the S&P500.

Standex International Corporation (SXI) formed multiple top with $108.71 target or 4.00% above today’s $104.53 share price. Standex International Corporation (SXI) has $1.34B valuation. The stock increased 0.80% or $0.83 during the last trading session, reaching $104.53. About 1,621 shares traded. Standex International Corporation (NYSE:SXI) has risen 11.03% since December 6, 2016 and is uptrending. It has underperformed by 5.67% the S&P500.

Investors sentiment decreased to 1.09 in Q2 2017. Its down 0.20, from 1.29 in 2017Q1. It fall, as 11 investors sold Standex International Corporation shares while 42 reduced holdings. 16 funds opened positions while 42 raised stakes. 10.09 million shares or 2.42% less from 10.34 million shares in 2017Q1 were reported. Geode Capital Management Ltd Liability Corp accumulated 0% or 99,825 shares. Tygh Capital Mgmt accumulated 71,984 shares. Piedmont Investment Advisors Lc has invested 0.01% of its portfolio in Standex International Corporation (NYSE:SXI). Us Savings Bank De has 0% invested in Standex International Corporation (NYSE:SXI) for 3,121 shares. National Bank & Trust Of America De owns 32,225 shares or 0% of their US portfolio. Royal Bank & Trust Of Canada accumulated 248,872 shares or 0.01% of the stock. Jpmorgan Chase & accumulated 38,755 shares or 0% of the stock. Copeland Capital Management Lc reported 118,761 shares or 0.7% of all its holdings. Millennium Limited Company has invested 0% in Standex International Corporation (NYSE:SXI). Bryn Mawr Com accumulated 0.51% or 94,072 shares. Nationwide Fund stated it has 15,163 shares. Burney Co holds 4,235 shares or 0.03% of its portfolio. Swiss Bank & Trust has invested 0% in Standex International Corporation (NYSE:SXI). Bnp Paribas Arbitrage Sa reported 4,187 shares. Schwab Charles Management invested 0.01% of its portfolio in Standex International Corporation (NYSE:SXI).

Analysts await Standex International Corporation (NYSE:SXI) to report earnings on February, 2. They expect $1.03 EPS, up 1.98% or $0.02 from last year’s $1.01 per share. SXI’s profit will be $13.17M for 25.37 P/E if the $1.03 EPS becomes a reality. After $1.35 actual EPS reported by Standex International Corporation for the previous quarter, Wall Street now forecasts -23.70% negative EPS growth.

Among 6 analysts covering Standex Int’l Corp. (NYSE:SXI), 4 have Buy rating, 0 Sell and 2 Hold. Therefore 67% are positive. Standex Int’l Corp. has $116 highest and $98.0 lowest target. $110’s average target is 5.23% above currents $104.53 stock price. Standex Int’l Corp. had 7 analyst reports since August 11, 2015 according to SRatingsIntel. Wunderlich maintained the stock with “Buy” rating in Thursday, August 27 report. The stock of Standex International Corporation (NYSE:SXI) has “Buy” rating given on Monday, July 17 by FBR Capital. The stock of Standex International Corporation (NYSE:SXI) has “Neutral” rating given on Monday, December 19 by Sidoti. The rating was initiated by CJS Securities on Monday, December 12 with “Market Perform”. The firm has “Sell” rating by Zacks given on Tuesday, August 11. C.L. King initiated Standex International Corporation (NYSE:SXI) on Wednesday, November 29 with “Buy” rating.

Blair William & Company decreased Wisdomtree Trust Equity Income Fund Etf (DHS) stake by 9,115 shares to 12,420 valued at $849,000 in 2017Q2. It also reduced Epam Systems Inc (NYSE:EPAM) stake by 4,302 shares and now owns 29,137 shares. General Electric Co (NYSE:GE) was reduced too.

Investors sentiment increased to 1 in Q2 2017. Its up 0.01, from 0.99 in 2017Q1. It increased, as 55 investors sold ABBV shares while 581 reduced holdings. 138 funds opened positions while 500 raised stakes. 1.04 billion shares or 0.53% more from 1.04 billion shares in 2017Q1 were reported. Barton Inv Mngmt holds 0.17% or 8,994 shares in its portfolio. Fruth Inv Mngmt reported 1.26% in AbbVie Inc. (NYSE:ABBV). Blb&B Advsrs Limited Co holds 0.72% or 65,090 shares in its portfolio. Mu Invests Limited stated it has 420 shares or 0.02% of all its holdings. Silvercrest Asset Mngmt Ltd Liability Corporation reported 0.18% in AbbVie Inc. (NYSE:ABBV). Legal & General Gru Public Ltd Co stated it has 0.47% of its portfolio in AbbVie Inc. (NYSE:ABBV). Aviance Capital Management Ltd Liability Company owns 183,093 shares or 0.83% of their US portfolio. Gabelli Funds Ltd Liability reported 0.04% in AbbVie Inc. (NYSE:ABBV). Chilton Capital Mngmt Ltd Liability Com holds 11,100 shares or 0.09% of its portfolio. Mcrae Management has 0.12% invested in AbbVie Inc. (NYSE:ABBV). National Bank & Trust Of America De holds 18.02 million shares. Sun Life Financial owns 0.12% invested in AbbVie Inc. (NYSE:ABBV) for 14,891 shares. Pnc Service Grp holds 0.37% of its portfolio in AbbVie Inc. (NYSE:ABBV) for 4.79M shares. Compton Cap Ri accumulated 27,965 shares. 1832 Asset Mngmt Limited Partnership accumulated 7,210 shares or 0% of the stock.

Among 21 analysts covering Abbvie Inc (NYSE:ABBV), 11 have Buy rating, 1 Sell and 9 Hold. Therefore 52% are positive. Abbvie Inc had 69 analyst reports since July 21, 2015 according to SRatingsIntel. The rating was maintained by Goldman Sachs on Friday, March 10 with “Buy”. SunTrust maintained the stock with “Buy” rating in Monday, October 16 report. Cowen & Co maintained AbbVie Inc. (NYSE:ABBV) on Tuesday, September 5 with “Hold” rating. The firm has “Buy” rating by SunTrust given on Sunday, October 29. The stock of AbbVie Inc. (NYSE:ABBV) earned “Buy” rating by Jefferies on Monday, May 29. On Friday, December 18 the stock rating was initiated by Atlantic Securities with “Neutral”. Morgan Stanley upgraded the shares of ABBV in report on Monday, November 2 to “Overweight” rating. The rating was upgraded by Jefferies on Monday, December 7 to “Buy”. The rating was maintained by Jefferies on Monday, July 17 with “Buy”. BMO Capital Markets downgraded the stock to “Market Perform” rating in Friday, June 10 report.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: